These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19838051)

  • 1. p53 sumoylation: mechanistic insights from reconstitution studies.
    Wu SY; Chiang CM
    Epigenetics; 2009 Oct; 4(7):445-51. PubMed ID: 19838051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
    Kahyo T; Nishida T; Yasuda H
    Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation.
    Pelisch F; Gerez J; Druker J; Schor IE; Muñoz MJ; Risso G; Petrillo E; Westman BJ; Lamond AI; Arzt E; Srebrow A
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16119-24. PubMed ID: 20805487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
    Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
    Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.
    Cheema A; Knights CD; Rao M; Catania J; Perez R; Simons B; Dakshanamurthy S; Kolukula VK; Tilli M; Furth PA; Albanese C; Avantaggiati ML
    J Cell Physiol; 2010 Nov; 225(2):371-84. PubMed ID: 20458745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylated SnoN represses transcription in a promoter-specific manner.
    Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
    J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.
    Wu SY; Chiang CM
    EMBO J; 2009 May; 28(9):1246-59. PubMed ID: 19339993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
    Gocke CB; Yu H; Kang J
    J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.